• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9548
Device Problems Difficult to Advance (2920); Device Dislodged or Dislocated (2923)
Patient Problems Discomfort (2330); No Code Available (3191)
Event Date 09/01/2020
Event Type  Injury  
Event Description
It was reported that stent dislodgement occurred.The target lesion was located in the heavily calcified and previously stented left anterior descending artery/diagonal vessel.Predilatation was performed with drug-eluting balloon catheter.The patient experienced some discomfort during inflation but was otherwise was okay.A 12 x 2.25 promus premier drug-eluting stent was advanced for treatment.However, the device failed to deliver and it came off the balloon upon removal.Subsequently, the undeployed stent was crushed with another stent in the left main.Patient was admitted for 48 hours for observation and was discharged after.
 
Event Description
It was reported that stent dislodgement occurred.The target lesion was located in the heavily calcified and previously stented left anterior descending artery/diagonal vessel.Predilatation was performed with drug-eluting balloon catheter.The patient experienced some discomfort during inflation but was otherwise was okay.A 12 x 2.25 promus premier drug-eluting stent was advanced for treatment.However, the device failed to deliver and it came off the balloon upon removal.Subsequently, the undeployed stent was crushed with another stent in the left main.Patient was admitted for 48 hours for observation and was discharged after.It was further reported that the lesion had 95% stenosis with moderate bend.Resistance was encountered during advancing in the highly calcified lesion and passed through previously implanted stents.The device held pressure when attempting to deploy and no leaks were noted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10520461
MDR Text Key206491382
Report Number2134265-2020-12617
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/11/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/19/2021
Device Model Number9548
Device Catalogue Number9548
Device Lot Number0024823929
Was Device Available for Evaluation? No
Date Manufacturer Received09/29/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-